✦ LIBER ✦

Lupus nephritis in southern Chinese patients: Clinicopathologic findings and long-term outcome

✍ Scribed by Chi Chiu Mok; Raymond Woon-Sing Wong; Chak Sing Lau

Book ID: 117444625
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 67 KB
Volume: 34
Category: Article
ISSN: 0272-6386
DOI: 10.1016/s0272-6386(99)70361-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lupus Nephritis in Thailand: Clinicopath

Lupus Nephritis in Thailand: Clinicopathologic findings and outcome in 569 patients

✍ Shayakul, Chairat; Ong-aj-yooth, Leena; Chirawong, Phisit; Nimmannit, Sumalee; P 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 776 KB

Interstitial inflammation and long-term

Interstitial inflammation and long-term renal outcomes in lupus nephritis

✍ Alsuwaida, A. 📂 Article 📅 2013 🏛 SAGE Publications 🌐 English ⚖ 216 KB

P6 Clinicopathological study and treatme

P6 Clinicopathological study and treatment outcome in 31 patients of lupus nephritis

✍ MN Singh; NK Singh; A Agrawal; LK Pandey; RG Singh; J Shukla 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Long-term mortality and renal outcome in

Long-term mortality and renal outcome in a cohort of 100 patients with Lupus Nephritis

✍ Mikkel Faurschou; Lene Dreyer; Anne-Lise Kamper; Henrik Starklint; Søren Jacobse 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 103 KB 👁 2 views

Long-term renal outcome and complication

Long-term renal outcome and complications in South Africans with proliferative lupus nephritis

✍ Olugbenga E. Ayodele, Ikechi G. Okpechi… 📂 Article 📅 2013 🏛 Springer Netherlands 🌐 English ⚖ 309 KB

Early response to immunosuppressive ther

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial

✍ Frédéric A. Houssiau; Carlos Vasconcelos; David D'Cruz; Gian Domenico Sebastiani 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Abstract ## Objective In the Euro‐Lupus Nephritis Trial (ELNT), 90 patients with lupus nephritis were randomly assigned to a high‐dose intravenous cyclophosphamide (IV CYC) regimen (6 monthly pulses and 2 quarterly pulses with escalating doses) or a low‐dose IV CYC regimen (6 pulses of 500 mg g